FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientist

AI justification

FDA's authorization without full safety review undermines public health and regulatory integrity. | The FDA's authorization of Zyn nicotine pouches aims to reduce harm from combustible tobacco, a positive public health step. However, the lack of full compositional review and potential microplastic risks constitutes a significant ethical violation, undermining consumer safety and regulatory trust. The net judgment balances harm reduction potential against procedural negligence.